Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07625254 · ClinicalTrials.gov registry record · NA
Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07625254: Clinical Trial NA study, sponsored by University of California, San Francisco.
NCT07625254 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07625254, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether an arts-based storytelling and narrative medicine workshop series can improve social connection, illness identity, and psychological well-being in adolescents and young adults with chronic illness, specifically diabetes. The main questions it aims to answer are: * Does participation in a narrative-based storytelling workshop improve social connectedness and peer support among adolescents and young adults with diabetes? * Does engagement in creative arts and reflective storytelling support identity formation, self-expression, and emotional well-being in this population? Participants will be 16-25 years old and recruited through the UCSF Pediatric Diabetes Clinic. Individuals must be able to participate in group workshops and complete surveys and interviews related to the study. Participants will: * Attend eight weekly workshops centered on storytelling, reflection, and creative expression * Engage in narrative medicine activities, including writing, storytelling, drawing, and facilitated reflection * Participate in group discussions focused on personal experiences with chronic illness * Complete pre- and post-intervention surveys assessing psychosocial outcomes such as social connectedness, illness identity, self-concept, and mental well-being * Participate in interviews and reflective exercises about their experiences in the program This study aims to explore the role of narrative medicine and arts-based interventions in supporting adolescents and young adults with chronic illness and assess their potential benefits as a supplement to standard medical care.
Primary Outcome
Feasibility will be assessed by tracking the number of participants who attend each of the 8 weekly sessions, including overall completion of the program.
Interventions
- BEHAVIORAL Arts-Based Storytelling Workshop Series
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-09 |
| Phase | NA |
What is known before NCT07625254 opens enrollment
NCT07625254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Arts-Based Storytelling Workshop Series is the first listed.
NCT07625254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07625254 about?
NCT07625254 is a clinical study titled "Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes". The goal of this clinical trial is to evaluate whether an arts-based storytelling and narrative medicine workshop series can improve social connection, illness identity, and psychological well-being in adolescents and young adults with chronic illness, specifically diabetes. The main questions it a...
What is the current status of trial NCT07625254?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-06. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07625254?
The interventions under investigation include: Arts-Based Storytelling Workshop Series (BEHAVIORAL).
Who is sponsoring clinical trial NCT07625254?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07625254's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia